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Introduction
A series of cell-line specific complex media supplements
have been developed for enhancing performance of var-
ious biopharmaceutical production systems. Created
using in-house media optimization methods, these sup-
plements are manufactured using innovative, proprietary
process technology which allows for the combination of
complex and/or chemically defined animal-component
free media additives into a single homogeneous func-
tional supplement. These supplements have been opti-
mized for individual cell lines, and have proven to be
suitable for use in a range of basal media. Data are pre-
sented which demonstrate the effectiveness of these
optimized supplements as performance enhancers for
application in CHO and SP2/0 batch culture, and as
feed supplements in fed-batch systems. Preliminary data
will also be presented on a parallel series of strictly che-
mically-defined supplements, similarly optimized for
specific cell lines.
Materials and methods
CHO data were collected using a transfected CHO-K1
line (ATCC #CCL-61), adapted to serum-free suspen-
sion culture, and engineered to constitutively express
secreted embryonic alkaline phosphatase (SEAP) by
means of a modified human cytomegalovirus (hCMV)
promoter.
Hybridoma data were collected using a murine hybri-
doma suspension cell line (ATCC # CRL-1753). This
line was derived from primary spleen cell cultures of
animals immunized with purified human immunoglobu-
lin. These spleen cells were then fused with Sp2/0-Ag14
myeloma cells to create the hybridoma.
Triplicate 125 ml shake-flasks contained a final med-
ium volume of 35 ml. Duplicate spinner flasks had a
working volume of 150 ml. The basal medium consisted
of 100% chemically defined medium (CDM). Cultures
were incubated at 37°C in 5% CO2. Medium supplement
stock solutions were prepared at 100 g/l in the basal
medium and sterilized through a 2.0 µm filter.
At appropriate points during each experiment, 1.0 ml
of the culture supernatants were removed for assessing
cell counts and viability. Cells were counted using a
Nova BioProfile Flex automated analyzer. On the final
day of each run, 500 µl of the culture supernatants were
removed for SEAP or IgG analysis. Levels of SEAP in
the supernatants were measured using anion-exchange
HPLC on a Waters Model 2695 HPLC separations mod-
ule equipped with a dual-wavelength absorbance detec-
tor. IgG was quantified using a Protein G affinity
column.
Results
Using in-house media optimization methods, both an
undefined and a chemically-defined supplement for
CHO cells were developed from a variety of individual
components. The most favorable dosage for each sup-
plement was determined through a series of dose-
response experiments. While both supplements
improved cell culture performance, the undefined sup-
plement achieved a significantly higher peak cell density
than the chemically defined supplement (Figure 1). * Correspondence: james.babcock@kerry.com
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improved when the supplements were employed (Figure
1). As reflected in the growth data, the undefined pro-
vided a significantly greater benefit. While the titer
increase for the chemically-defined supplement was sub-
stantial, there was little increase in the Qp. The signifi-
cant Qp increase seen with the undefined supplement
undoubtedly accounts for the higher SEAP titer
Figure 1 Performance comparison of defined and undefined medium supplements in CHO batch culture
Babcock et al. BMC Proceedings 2011, 5(Suppl 8):P25
http://www.biomedcentral.com/1753-6561/5/S8/P25
Page 2 of 3obtained, and may be a function of un-characterized ele-
ments within the hydrolysate based supplement.
Summary
Medium optimization is an integral part of biopharma-
ceutical process development. There is an on-going
debate within the industry as to the various advantages
and disadvantages of both defined and undefined media
and media components. The choice of which type of
system to employ is often motivated by risk mitigation
with respect to consistency of performance, as weighed
against the underlying goal of achieving the highest pos-
sible product titers for any given system. Defined and
undefined supplementation solutions may not be
mutually exclusive.
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